Nick Pizzie, Chief Financial Officer at Axsome Therapeutics, Inc. (AXSM), bought 1,554 shares at $76.64 ($119K) on 2020-06-29, disclosed to the SEC on 2020-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.64 | 777 | $60K | 50.0% |
| 2 | $76.64 | 777 | $60K | 50.0% |
| Total | $76.64 avg | 1,554 | $119K | 100% |
| Filing → |
| AXSM | SELL | 2025-02-14 | $3.5M | — | Filing → |
| AXSM | BUY | 2021-11-22 | $34K | — | Filing → |
| AXSM | BUY | 2019-09-30 | $54K | — | Filing → |